Mga Batayang Estadistika
| CIK | 1173293 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Novadaq Technologies Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 66987G102 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| October 11, 2017 |
Novadaq Technologies 15F-12B/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F (Amendment No. 1) CERTIFICATION OF A FOREIGN PRIVATE ISSUERS TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number |
|
| September 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F CERTIFICATION OF A FOREIGN PRIVATE ISSUER?S TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35446 NOVADA |
|
| September 11, 2017 |
EX-99.1 2 a17-215732ex99d1.htm EX-99.1 Exhibit 99.1 NOVADAQ ANNOUNCES FILING WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION TO TERMINATE THE REGISTRATION OF ITS COMMON SHARES Toronto, Ontario — September 11, 2017 — NOVADAQ Technologies Inc. (NASDAQ: NVDQ) (“NOVADAQ” or the “Corporation”) today announced that, it has filed a Form 15F with the United States Securities and Exchange Commiss |
|
| September 11, 2017 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| September 5, 2017 |
NVDQ / Novadaq Technologies, Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Novadaq Technologies Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 66987G102 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person |
|
| September 1, 2017 |
As filed with the Securities and Exchange Commission on September 1, 2017 Registration No. |
|
| September 1, 2017 |
As filed with the Securities and Exchange Commission on September 1, 2017 Registration No. |
|
| September 1, 2017 |
NOVADAQ Announces Completion of Plan of Arrangement EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 NOVADAQ Announces Completion of Plan of Arrangement TORONTO, Sept. 01, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”) today announced completion of its previously announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), pursuant to which, among other thin |
|
| September 1, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| August 16, 2017 |
NVDQ / Novadaq Technologies, Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Novadaq Technologies Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 66987G102 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Rece |
|
| August 11, 2017 |
Novadaq Technologies 6-K-Q2-FS (Current Report of Foreign Issuer) ndq-6k20170811.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 |
|
| August 11, 2017 |
ndq-ex9919.htm Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at June 30, 2017 As at December 31, 2016 ASSETS Current assets Cash and cash equivalents $ 49,589,689 $ 62,382,649 Accounts receivable 27,522,109 27,791,574 Prepaid expenses and other assets 6,078,71 |
|
| August 9, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regis |
|
| August 9, 2017 |
NOVADAQ Receives Court Approval for Arrangement With Stryker EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 NOVADAQ Receives Court Approval for Arrangement With Stryker TORONTO, Aug. 09, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”) today announced that the Ontario Superior Court of Justice has issued a final order approving its previously announced plan of arrangement (the “Arrangement”) under t |
|
| August 4, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k080417.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Can |
|
| August 4, 2017 |
Novadaq Announces Voting Results of Special Meeting of Shareholders EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Novadaq Announces Voting Results of Special Meeting of Shareholders TORONTO, Aug. 04, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”) today announced that at the special meeting (the “Meeting”) of the shareholders of the Corporation (the “Shareholders”) held earlier today, Shareholders overwh |
|
| August 3, 2017 |
NVDQ / Novadaq Technologies, Inc. / JP Morgan Chase & Co Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(c) ( AMENDMENT 6) NOVADAQ TECHNOLOGIES INC. |
|
| July 24, 2017 |
EdgarFiling EXHIBIT 99.1 Leading Advisory Firms ISS and Glass Lewis Support Plan of Arrangement Between NOVADAQ Technologies Inc. and Stryker Corporation TORONTO, July 24, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (?NOVADAQ? or the ?Corporation?), is pleased to announce that both Institutional Shareholder Services (?ISS?) and Glass, Lewis & Co. (?Glass Lewis?) have |
|
| July 24, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| July 13, 2017 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registran |
|
| July 13, 2017 |
EX-99.1 2 a17-159734ex99d1.htm EX-99.1 Exhibit 99.1 Notice of Meeting and Management Information Circular For the Special Meeting of Shareholders of NOVADAQ Technologies Inc. To be held on Friday, August 4, 2017 The Board of Directors Unanimously Recommends that Shareholders Vote FOR the Arrangement Resolution July 6, 2017 This document is important and requires your immediate attention. If you ar |
|
| July 12, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| July 12, 2017 |
NOVADAQ Mails Information Circular for Special Meeting of Shareholders EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 NOVADAQ Mails Information Circular for Special Meeting of Shareholders TORONTO, July 12, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”) today announced that it has mailed the management information circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of the |
|
| June 20, 2017 |
FORM 51–102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 Exhibit 99.1 Exhibit 99.1 FORM 51?102F3 MATERIAL CHANGE REPORT UNDER NATIONAL INSTRUMENT 51-102 Item 1 Name and Address of Company Novadaq Technologies Inc. 5090 Explorer Drive, Suite 202 Mississauga, Ontario L4W 4T9 Item 2 Date of Material Change June 16, 2017. Item 3 News Release A news release was issued by Novadaq Technologies Inc. (?Novadaq?) on June 19, 2017 and distributed through GlobeNews |
|
| June 20, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of |
|
| June 20, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of |
|
| June 20, 2017 |
EX-99.1 2 d416035dex991.htm EXHIBIT 99.1 Exhibit 99.1 NOVADAQ TECHNOLOGIES INC. AND STRYKER CANADA OPERATIONS ULC AND STRYKER CORPORATION ARRANGEMENT AGREEMENT Dated June 16, 2017 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 1 1.1 Definitions 1 1.2 Interpretation Not Affected by Headings 18 1.3 Number and Gender 18 1.4 Computation of Time 18 1.5 Time References 18 1.6 Currency 18 1.7 Accounting |
|
| June 19, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| June 19, 2017 |
NOVADAQ Enters Into Agreement to be Acquired by Stryker Corporation EdgarFiling EXHIBIT 99.1 NOVADAQ Enters Into Agreement to be Acquired by Stryker Corporation TORONTO, June 19, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ) (“NOVADAQ” or the “Corporation”), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, toda |
|
| June 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Novadaq Technologies Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 66987G102 (CUSIP Number) June 07, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ |
|
| June 7, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| June 7, 2017 |
NOVADAQ to Present at the Upcoming JMP Securities 2017 Life Sciences Conference EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 NOVADAQ to Present at the Upcoming JMP Securities 2017 Life Sciences Conference TORONTO, June 07, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, to |
|
| May 4, 2017 |
EX-99.1 2 ndq-ex9916.htm EX-99.1 Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at March 31, 2017 As at December 31, 2016 ASSETS Current assets Cash and cash equivalents $ 56,139,164 $ 62,382,649 Accounts receivable 28,430,680 27,791,574 Prepaid expenses and ot |
|
| May 4, 2017 |
Novadaq Technologies 6-K-05-02-2017 (Current Report of Foreign Issuer) ndq-6k20170331.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (A |
|
| May 3, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| May 3, 2017 |
NOVADAQ Announces First Quarter 2017 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE Exhibit 99.1 NOVADAQ Announces First Quarter 2017 Financial Results TORONTO, May 03, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial resul |
|
| April 19, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regist |
|
| April 19, 2017 |
NOVADAQ to Report First Quarter 2017 Financial results on May 3, 2017 EX-99.1 2 exh991.htm PRESS RELEASE Exhibit 99.1 NOVADAQ to Report First Quarter 2017 Financial results on May 3, 2017 TORONTO, April 19, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today annou |
|
| March 22, 2017 |
ndq-ex991110.htm Exhibit 99.1 For the financial year ended December 31st, 2016 March 22nd, 2017 TABLE OF CONTENTS ITEM 1. CORPORATE STRUCTURE 4 1.1 Name, Address and Incorporation 4 1.2 Inter-Corporate Relationships 4 ITEM 2. GENERAL DEVELOPMENT OF THE BUSINESS 4 2.1 Overview 4 2.2 Three-Year History 6 ITEM 3. NARRATIVE DESCRIPTION OF THE BUSINESS 9 3.1 General 9 3.2 Business Strategy 12 3.3 Busin |
|
| March 22, 2017 |
EX-99 3 ndq-ex992111.htm EX-99.2 Exhibit 99.2 March 22nd, 2017 Table of Contents Letter to Shareholders 3 Management’s Discussion & Analysis of Financial Condition and Results of Operations 5 Management’s Responsibility for Financial Reporting and Report on Internal Control over Financial Reporting 28 Independent Auditors’ Reports 30 Consolidated Financial Statements 32 Notes to Consolidated Finan |
|
| March 22, 2017 |
Novadaq Technologies FORM 40-F ndq-10q20170322.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [Check one] ? REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Commission File Number 001-35446 NOVADAQ TECHNOLOGIES INC. (Ex |
|
| March 1, 2017 |
Novadaq Technologies 6-K-03-01-2017 (Current Report of Foreign Issuer) 6-K 1 ndq-6k20170301.htm 6-K-03-01-2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ont |
|
| March 1, 2017 |
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING Exhibit 99.1 MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING The accompanying consolidated financial statements of Novadaq Technologies Inc. (the “Company”) and all the information in this annual report are the responsibility of management and have been approved by the Board of Directors. The financial statements have been prepared by management in accordance with International Financial Repor |
|
| February 28, 2017 |
NOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results EXHIBIT 99.1 NOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results TORONTO, Feb. 28, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial results for the three mo |
|
| February 28, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| February 15, 2017 |
NOVADAQ to Report Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017 EdgarFiling EXHIBIT 99.1 NOVADAQ to Report Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017 TORONTO, Feb. 15, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced |
|
| February 15, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| February 13, 2017 |
NVDQ / Novadaq Technologies, Inc. / Arrowpoint Asset Management, LLC - 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2017 |
NVDQ / Novadaq Technologies, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 9, 2017 |
NVDQ / Novadaq Technologies, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D. |
|
| February 8, 2017 |
NOVADAQ Announces Participation in Upcoming Investor Conferences EdgarFiling EXHIBIT 99.1 NOVADAQ Announces Participation in Upcoming Investor Conferences TORONTO, Feb. 08, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it plans to partici |
|
| February 8, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k020717.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, C |
|
| February 6, 2017 |
NVDQ / Novadaq Technologies, Inc. / PRUDENTIAL FINANCIAL INC Passive Investment 13G HTML File DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 19, 2017 |
Exhibit 99.2 Exhibit 99.2 Execution Version CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of January 6, 2017 by and among NOVADAQ TECHNOLOGIES INC. and NOVADAQ CORP., and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE ADDITIONAL LENDERS FROM TIME TO TIME PARTY HERETO TA |
|
| January 19, 2017 |
FORM 51-102F3 MATERIAL CHANGE REPORT EX-99.1 2 d313690dex991.htm EXHIBIT 99.1 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Novadaq Technologies Inc. (“NOVADAQ”) 5090 Explorer Drive Suite 202 Mississauga, Ontario L4W 4T9 Item 2 Dates of Material Change January 6, 2017 Item 3 News Release A news release with respect to the material change referred to in this report was issued by NOVADAQ through t |
|
| January 19, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) 6-K 1 d313690d6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2017 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Ca |
|
| January 19, 2017 |
Exhibit 99.3 Exhibit 99.3 Execution Version CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) dated as of January 6, 2017 by and among NOVADAQ TECHNOLOGIES INC. and NOVADAQ CORP., and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE ADDITIONAL LENDERS FROM TIME TO TIME PARTY HERE |
|
| January 10, 2017 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue and Issues 2017 Revenue Guidance Secures Up to $60 Million in Financing From MidCap Financial TORONTO, Jan. 10, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc (NASDAQ:NVDQ) (TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical |
|
| January 10, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| January 4, 2017 |
NOVADAQ Appoints Lisa Colleran to Its Board of Directors EdgarFiling EXHIBIT 99.1 NOVADAQ Appoints Lisa Colleran to Its Board of Directors TORONTO, Jan. 04, 2017 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (?NOVADAQ? or the ?Company?) (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Lisa Colleran has been appointed to it |
|
| January 4, 2017 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2017 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| December 6, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| December 6, 2016 |
NOVADAQ to Present at the 35th Annual J.P. Morgan Healthcare Conference EdgarFiling EXHIBIT 99.1 NOVADAQ to Present at the 35th Annual J.P. Morgan Healthcare Conference TORONTO, Dec. 06, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President |
|
| November 22, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| November 22, 2016 |
NOVADAQ to Present at the 28th Annual Piper Jaffray Healthcare Conference EdgarFiling EXHIBIT 99.1 NOVADAQ to Present at the 28th Annual Piper Jaffray Healthcare Conference TORONTO, Nov. 22, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, Presiden |
|
| November 8, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| November 8, 2016 |
NOVADAQ to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum EdgarFiling EXHIBIT 99.1 NOVADAQ to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum TORONTO, Nov. 08, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Man |
|
| November 3, 2016 |
ndq-ex9918.htm Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at September 30, 2016 As at December 31, 2015 ASSETS Current assets Cash and cash equivalents $ 72,242,278 $ 106,790,202 Accounts receivable 27,147,891 21,767,746 Prepaid expenses and other assets 5, |
|
| November 3, 2016 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) ndq-6k20161103.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4 |
|
| November 2, 2016 |
NOVADAQ Reports Third Quarter 2016 Financial Results EdgarFiling EXHIBIT 99.1 NOVADAQ Reports Third Quarter 2016 Financial Results TORONTO, Nov. 02, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third quarter ended Se |
|
| November 2, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| October 21, 2016 |
EdgarFiling EXHIBIT 99.1 NOVADAQ to Release Third Quarter 2016 Financial Results on November 2, 2016?Conference Call to Follow TORONTO, Oct. 20, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce f |
|
| October 21, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| October 7, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 October 2016 Commission File Number: 001-35446 NOVADAQ TECHNOLOGIES INC. (Translation of registrant's name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registrant?s principa |
|
| October 7, 2016 |
NOVADAQ to Host Analyst and Investor Day on November 14, 2016 EdgarFiling EXHIBIT 99.1 NOVADAQ to Host Analyst and Investor Day on November 14, 2016 TORONTO, Oct. 05, 2016 (GLOBE NEWSWIRE) - NOVADAQ Technologies Inc. (?NOVADAQ? or the ?Company?) (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November |
|
| September 6, 2016 |
NOVADAQ Announces Appointment of Karen A. Licitra to its Board of Directors Novadaq Technologies Inc.: Form 6-K- Filed by newsfilecorp.com For Immediate Release NOVADAQ Announces Appointment of Karen A. Licitra to its Board of Directors Toronto, Ontario ? September 6, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnost |
|
| September 6, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrants name into English) 5090 Explorer Drive |
|
| August 25, 2016 |
NOVADAQ to Present at the 2016 Morgan Stanley Global Healthcare Conference Novadaq Technologies: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Present at the 2016 Morgan Stanley Global Healthcare Conference Toronto, Ontario ? August 25, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic |
|
| August 25, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Su |
|
| August 25, 2016 |
NOVADAQ to Present at the 2016 Morgan Stanley Global Healthcare Conference Novadaq Technologies: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Present at the 2016 Morgan Stanley Global Healthcare Conference Toronto, Ontario ? August 25, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic |
|
| August 25, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Su |
|
| July 29, 2016 |
NOVADAQ to Participate in August Investor Conferences Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Participate in August Investor Conferences Toronto, Ontario ? July 29, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announ |
|
| July 29, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suit |
|
| July 28, 2016 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 Exhibit 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Rick Mangat, President and Chief Executive Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended June 30, 2016. 2. No misrepres |
|
| July 28, 2016 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.4 Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Roger Deck, Chief Financial Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended June 30, 2016. 2. No misrepresentations: Base |
|
| July 28, 2016 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| July 28, 2016 |
EX-99.1 Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at June 30, 2016 As at December 31, 2015 ASSETS Current assets Cash and cash equivalents $ 84,034,658 $ 106,790,202 Accounts receivable 23,722,377 21,767,746 Prepaid expenses and other assets 5,157,489 3,36 |
|
| July 28, 2016 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 Exhibit 99.2 NOVADAQ Technologies Inc. Management?s Discussion and Analysis Three and Six Month periods ended June 30, 2016 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management?s Discussion and Analysis [?MD&A?] for NOVADAQ? Technologies Inc. [?NOVADAQ? or the ?Company?] should be read in conjunction with the unaudited interim condensed cons |
|
| July 27, 2016 |
NOVADAQ Reports Second Quarter 2016 Financial Results Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Reports Second Quarter 2016 Financial Results Toronto, Ontario ? July 27, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today |
|
| July 27, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suit |
|
| July 11, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suit |
|
| July 11, 2016 |
Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release Second Quarter 2016 Financial Results on July 27, 2016 Conference Call to Follow Toronto, Ontario July 11, 2016 NOVADAQ Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for u |
|
| July 6, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suit |
|
| July 6, 2016 |
NOVADAQ Announces Appointment of Rick Mangat as President and CEO Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Announces Appointment of Rick Mangat as President and CEO Toronto, Ontario July 6, 2016 - NOVADAQ® Technologies Inc. (NOVADAQ or the Company) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announc |
|
| May 26, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite |
|
| May 26, 2016 |
NOVADAQ to Participate in June Investor Conferences EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ to Participate in June Investor Conferences Toronto, Ontario – May 26, 2016 - NOVADAQ Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will p |
|
| May 20, 2016 |
NOVADAQ REPORTS VOTING RESULTS FROM ANNUAL MEETING OF SHAREHOLDERS EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ REPORTS VOTING RESULTS FROM ANNUAL MEETING OF SHAREHOLDERS Toronto, Ontario – May 20, 2016 – NOVADAQ® Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced that at the annual meetin |
|
| May 20, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite |
|
| April 29, 2016 |
NOVADAQ to Participate in May Investor Conferences EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ to Participate in May Investor Conferences Toronto, Ontario – April 29, 2016 - NOVADAQ Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will |
|
| April 29, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| April 28, 2016 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) ndq-6k20160428.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 |
|
| April 28, 2016 |
ndq-ex9916.htm Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at March 31, 2016 As at December 31, 2015 ASSETS Current assets Cash and cash equivalents $ 96,607,988 $ 106,790,202 Accounts receivable 21,775,829 21,767,746 Prepaid expenses and other assets 3,026, |
|
| April 27, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| April 27, 2016 |
NOVADAQ Reports First Quarter 2016 Financial Results Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Reports First Quarter 2016 Financial Results Toronto, Ontario ? April 27, 2016 ? NOVADAQ Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today |
|
| April 11, 2016 |
NOVADAQ Technologies Inc. - Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release First Quarter 2016 Financial Results on April 27, 2016 Conference Call to Follow Toronto, Ontario April 11, 2016 NOVADAQ Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for |
|
| April 11, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) NOVADAQ Technologies Inc. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Su |
|
| March 31, 2016 |
NOVADAQ to Participate in the 15th Annual Needham Healthcare Conference For Immediate Release NOVADAQ to Participate in the 15th Annual Needham Healthcare Conference Toronto, Ontario March 31, 2016 - NOVADAQ Technologies Inc. |
|
| March 31, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| March 24, 2016 |
ndq-ex99166.htm Exhibit 99.1 TABLE OF CONTENTS ITEM 1. CORPORATE STRUCTURE 4 1.1 Name, Address and Incorporation 4 1.2 Inter-Corporate Relationships 4 ITEM 2. GENERAL DEVELOPMENT OF THE BUSINESS 4 2.1 Overview 4 2.2 Three-Year History 5 ITEM 3. NARRATIVE DESCRIPTION OF THE BUSINESS 9 3.1 General 9 3.2 Business Strategy 11 3.3 Business Operations 12 3.4 Manufacturing Operations 16 3.5 Alliances and |
|
| March 24, 2016 |
Novadaq Technologies FORM 40-F ndq-10q20151231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [Check one] ? REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Commission File Number 001-35446 NOVADAQ TECHNOLOGIES INC. (Ex |
|
| March 24, 2016 |
MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ndq-ex99268.htm Exhibit 99.2 Annual Report 2015 Novadaq Technologies Inc. Table of Contents Letter to Shareholders 2 Management?s Discussion & Analysis of Financial Condition and Results of Operations 4 Management?s Responsibility for Financial Reporting and Report on Internal Control over Financial Reporting 25 Independent Auditors? Reports 26 Consolidated Financial Statements 28 Notes to Consoli |
|
| March 1, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Sui |
|
| March 1, 2016 |
NOVADAQ to Participate in March Investor Conferences Novadaq Technologies Inc. - Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Participate in March Investor Conferences Toronto, Ontario ? March 1, 2016 - Novadaq Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announ |
|
| February 18, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| February 18, 2016 |
MANAGEMENT?S RESPONSIBILITY FOR FINANCIAL REPORTING ndq-ex99154.htm Exhibit 99.1 MANAGEMENT?S RESPONSIBILITY FOR FINANCIAL REPORTING The accompanying consolidated financial statements of Novadaq Technologies Inc. (the ?Company?) and all the information in this annual report are the responsibility of management and have been approved by the Board of Directors. The financial statements have been prepared by management in accordance with International |
|
| February 18, 2016 |
NOVADAQ Reports Fourth Quarter and Full Year 2015 Financial Results Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Reports Fourth Quarter and Full Year 2015 Financial Results Toronto, Ontario ? February 17, 2016 - Novadaq Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic |
|
| February 18, 2016 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regis |
|
| February 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 12, 2016 |
Novadaq Technologies SC 13G/A (Passive Acquisition of More Than 5% of Shares) UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D. |
|
| February 9, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| February 9, 2016 |
NOVADAQ to Participate in the RBC Capital Markets 2016 Global Healthcare Conference Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Participate in the RBC Capital Markets 2016 Global Healthcare Conference Toronto, Ontario February 9, 2016 - Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical |
|
| February 1, 2016 |
Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release Fourth Quarter and Full Year 2015 Financial Results on February 17, 2016 Conference Call to Follow Toronto, Ontario February 1, 2016 Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence im |
|
| February 1, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| January 28, 2016 |
NVDQ / Novadaq Technologies, Inc. / PRUDENTIAL FINANCIAL INC Passive Investment 13G HTML File DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 11, 2016 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2016 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive S |
|
| January 11, 2016 |
Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Announces Fourth Quarter 2015 Preliminary Unaudited Revenues and Issues 2016 Revenue Guidance Toronto, ON ? January 11, 2016 ? Novadaq Technologies Inc. (?NOVADAQ? or the ?Company?) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use |
|
| December 10, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| December 10, 2015 |
NOVADAQ to Present at the 34th Annual J.P. Morgan Healthcare Conference EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ to Present at the 34th Annual J.P. Morgan Healthcare Conference Toronto, Ontario – December 10, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announc |
|
| November 19, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| November 19, 2015 |
NOVADAQ to Participate in the 27th Annual Piper Jaffray Healthcare Conference Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Participate in the 27th Annual Piper Jaffray Healthcare Conference Toronto, Ontario November 18, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and d |
|
| November 2, 2015 |
NOVADAQ to Participate in November Investor Events For Immediate Release NOVADAQ to Participate in November Investor Events Toronto, Ontario November 2, 2015 - Novadaq Technologies Inc. |
|
| November 2, 2015 |
Novadaq Technologies FORM 6K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| October 29, 2015 |
Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at September 30, 2015 As at December 31, 2014 ASSETS Current assets Cash and cash equivalents $ 116,422,098 $ 141,447,544 Accounts receivable 18,735,791 13,503,303 Prepaid expenses and other assets 3,420,528 1,205, |
|
| October 29, 2015 |
NVDQ / Novadaq Technologies, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| October 29, 2015 |
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 Exhibit 99.2 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management?s Discussion and Analysis [?MD&A?] for NOVADAQ? Technologies Inc. [?NOVADAQ? or the ?Company?] should be read in conjunction with the unaudited interim condensed consolidated financial statements for the three month and nine month periods ended September 30, 2015, which have b |
|
| October 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Roger Deck, Chief Financial Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Novadaq Technologies Inc. (the issuer) for the interim period ended September 30, 2015. 2. No misrepresentations: Based o |
|
| October 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 Exhibit 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Arun Menawat, President and Chief Executive Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended September 30, 2015. 2. No mis |
|
| October 29, 2015 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| October 28, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regist |
|
| October 28, 2015 |
NOVADAQ Reports Third Quarter 2015 Financial Results Novadaq Technologies Inc. - Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Reports Third Quarter 2015 Financial Results Toronto, Ontario ? October 28, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, tod |
|
| October 14, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regist |
|
| October 14, 2015 |
Novadaq Technologies Inc. - Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release Third Quarter 2015 Financial Results on October 28, 2015 Conference Call to Follow Toronto, Ontario October 14, 2015 Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions |
|
| October 1, 2015 |
Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ and Arthrex Announce Co-Marketing Agreement for PINPOINT Fluorescence Imaging and 4K Synergy Systems Toronto, Ontario ? October 1 2015 ? Novadaq Technologies Inc. (?NOVADAQ? or the ?Company?) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutio |
|
| October 1, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrants name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regist |
|
| September 28, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.- Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| September 28, 2015 |
NOVADAQ Unveils SPY-Q Case Management Software at the SAWC Fall Symposium Novadaq Technologies Inc.- Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ Unveils SPY-Q Case Management Software at the SAWC Fall Symposium Toronto, Ontario September 28, 2015 - Novadaq® Technologies Inc. (NOVADAQ or the Company) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and dia |
|
| September 23, 2015 |
NOVADAQ to Host Analyst & Investor Day on November 16, 2015 For Immediate Release NOVADAQ to Host Analyst & Investor Day on November 16, 2015 Toronto, Ontario - September 22, 2015 - Novadaq® Technologies Inc. |
|
| September 23, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive |
|
| September 3, 2015 |
NOVADAQ to Present at the 2015 Morgan Stanley Global Healthcare Conference Novadaq Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Present at the 2015 Morgan Stanley Global Healthcare Conference Toronto, Ontario September 3, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diag |
|
| September 3, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| August 4, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| August 4, 2015 |
NOVADAQ to Present at the Canaccord Genuity 35th Annual Growth Conference EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ to Present at the Canaccord Genuity 35th Annual Growth Conference Toronto, Ontario – August 4, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the “Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced toda |
|
| July 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EXHIBIT 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Roger Deck, Chief Financial Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Novadaq Technologies Inc. (the issuer) for the interim period ended June 30, 2015. 2. No misrepresentations: Based on my |
|
| July 29, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Tecnologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite |
|
| July 29, 2015 |
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 EXHIBIT 99.2 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management?s Discussion and Analysis [?MD&A?] for NOVADAQ? Technologies Inc. [?NOVADAQ? or the ?Company?] should be read in conjunction with the unaudited interim condensed consolidated financial statements for the three month and six month periods ended June 30, 2015, which have been pr |
|
| July 29, 2015 |
EX-99.1 EXHIBIT 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at June 30, 2015 As at December 31, 2014 ASSETS Current assets Cash and cash equivalents $ 124,413,063 $ 141,447,544 Accounts receivable 15,292,482 13,503,303 Prepaid expenses and other assets 3,725,637 1,2 |
|
| July 29, 2015 |
NOVADAQ Reports Second Quarter 2015 Financial Results For Immediate Release NOVADAQ Reports Second Quarter 2015 Financial Results Toronto, Ontario July 28, 2015 - Novadaq Technologies Inc. |
|
| July 29, 2015 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| July 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 EXHIBIT 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Arun Menawat, President and Chief Executive Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended June 30, 2015. 2. No misrepre |
|
| July 14, 2015 |
Novadaq Technologies Inc.: Exhibit 99.1- Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release Second Quarter 2015 Financial Results on July 28, 2015 Conference Call to Follow Toronto, Ontario July 14, 2015 Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for us |
|
| July 14, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K- Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite |
|
| July 10, 2015 |
EX-99.4 Exhibit 99.4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 40-F/A of Novadaq Technologies Inc. (the ?Company?) for the fiscal year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Arun Menawat, President and |
|
| July 10, 2015 |
EX-99.7 Exhibit 99.7 KPMG LLP Yonge Corporate Centre 4100 Yonge St. Suite 200 North York, ON M2P 2H3 Telephone Fax Internet (416) 228-7000 (416) 228-7123 www.kpmg.ca Consent of Independent Registered Public Accounting Firm The Board of Directors Novadaq Technologies Inc. We consent to the use of: ? our Independent Auditors? Report of Registered Public Accounting Firm dated February 24, 2015 on the |
|
| July 10, 2015 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-99.6 Exhibit 99.6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the inclusion in this Annual Report on Form 40-F/A for the year ended December 31, 2014 of Novadaq Technologies Inc. [the ?Company?] of our report dated February 5, 2014 with respect to the consolidated financial statements of the Company as at and for the year ended December 31, 2013. We also consent to th |
|
| July 10, 2015 |
Exhibit 99.5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 40-F/A of Novadaq Technologies Inc. (the Company) for the fiscal year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Roger Deck, Chief Financial Officer |
|
| July 10, 2015 |
CORRESP July 10, 2015 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| July 10, 2015 |
40-F/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A (Amendment No. 1) [Check one] ? REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number 001-35446 NOVADAQ TECHNOLOGIES I |
|
| July 10, 2015 |
MANAGEMENTS RESPONSIBILITY FOR FINANCIAL REPORTING EX-99.1 Exhibit 99.1 MANAGEMENT?S RESPONSIBILITY FOR FINANCIAL REPORTING The accompanying consolidated financial statements of Novadaq Technologies Inc. (the ?Company?) and all the information in this annual report are the responsibility of management and have been approved by the Board of Directors. The financial statements have been prepared by management in accordance with International Financi |
|
| July 10, 2015 |
CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 EX-99.3 Exhibit 99.3 CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Roger Deck, certify that: 1. I have reviewed this annual report on Form 40-F/A of Novadaq Technologies Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light o |
|
| July 10, 2015 |
CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 EX-99.2 Exhibit 99.2 CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934 I, Arun Menawat, certify that: 1. I have reviewed this annual report on Form 40-F/A of Novadaq Technologies Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light |
|
| June 8, 2015 |
NVDQ / Novadaq Technologies, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Novadaq Technologies Inc. (Name of Issuer) Common (Title of Class of Securities) 66987G102 (CUSIP Number) May 31, 2015 (Date of Eve |
|
| June 4, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) 6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W |
|
| June 4, 2015 |
NOVADAQ to Present at the 35th Annual William Blair Stock Conference For Immediate Release NOVADAQ to Present at the 35th Annual William Blair Stock Conference Toronto, Ontario June 4, 2015 - Novadaq Technologies Inc. |
|
| May 14, 2015 |
NOVADAQ REPORTS VOTING RESULTS FROM ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS Novadaq Technologies, Inc.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ REPORTS VOTING RESULTS FROM ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS Toronto, Ontario ? May 14, 2015 ? Novadaq? Technologies Inc. ("NOVADAQ" or the "Company") (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic proc |
|
| May 14, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies, Inc.: Form 6-K- Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite |
|
| May 13, 2015 |
As filed with the Securities and Exchange Commission on May 13, 2015 Registration No. |
|
| May 13, 2015 |
EX-4.1 Exhibit 4.1 LONG TERM INCENTIVE PLAN Effective as of April 7, 2015 NOVADAQ TECHNOLOGIES INC. LONG TERM INCENTIVE PLAN The purpose of this Plan is to advance the interests of the Company by: (i) providing Eligible Persons with additional incentives; (ii) rewarding performance by Participants; (iii) increasing the proprietary interest of Participants in the success of the Company; (iv) encour |
|
| April 30, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Sui |
|
| April 30, 2015 |
NOVADAQ To Participate in May Investor Conferences EX-99.1 3 exhibit99-1.htm PRESS RELEASE DATED APRIL 30, 2015 For Immediate Release NOVADAQ To Participate in May Investor Conferences Toronto, ON - April 30, 2015 - Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that |
|
| April 29, 2015 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| April 29, 2015 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 3 d916954dex992.htm EX-99.2 Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management’s Discussion and Analysis [“MD&A”] for NOVADAQ® Technologies Inc. [“NOVADAQ” or the “Company”] should be read in conjunction with the unaudited interim condensed consolidated financial statements for the three month period ended March 31, 2015, whic |
|
| April 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 Exhibit 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Arun Menawat, President and Chief Executive Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended March 31, 2015. 2. No misrepr |
|
| April 29, 2015 |
EX-99.1 Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at March 31, 2015 As at December 31, 2014 ASSETS Current assets Cash and cash equivalents $ 133,014,195 $ 141,447,544 Accounts receivable 14,937,658 13,503,303 Prepaid expenses and other assets 2,191,903 1, |
|
| April 29, 2015 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.4 Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Roger Deck, Chief Financial Officer, Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Novadaq Technologies Inc. (the ?issuer?) for the interim period ended March 31, 2015. 2. No misrepresentations: Bas |
|
| April 28, 2015 |
NOVADAQ Reports First Quarter 2015 Financial Results Exhibit 99.1 For Immediate Release NOVADAQ Reports First Quarter 2015 Financial Results Toronto, Ontario April 28, 2015 - Novadaq Technologies Inc. ("NOVADAQ" or the Company") (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its first quarter ended |
|
| April 28, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) NOVADAQ TECHNOLOGIES INC.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Sui |
|
| April 15, 2015 |
NOVADAQ TECHNOLOGIES INC.: Exhibit 99.1 - Filed by newsfilecorp.com For Immediate Release NOVADAQ to Release First Quarter 2015 Financial Results on April 28, 2015 ? Conference Call to Follow Toronto, Ontario ? April 15, 2015 ? Novadaq Technologies Inc. ("NOVADAQ" or the ?Company") (NASDAQ:NVDQ;TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for u |
|
| April 15, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registra |
|
| March 26, 2015 |
4 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF EX-99.2 Exhibit 99.2 Annual Report 2014 Novadaq Technologies Inc. Table of Content Letter to Shareholders 2 Management?s Discussion & Analysis of Financial Condition and Results of Operations 5 Management?s Responsibility for Financial Reporting and Report on Internal Control over Financial Reporting 30 Independent Auditors? Reports 31 Consolidated Financial Statements 34 Notes to Consolidated Fin |
|
| March 26, 2015 |
40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [Check one] ? REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number 001-35446 NOVADAQ TECHNOLOGIES INC. (Exact name of Reg |
|
| March 26, 2015 |
EX-99.1 Exhibit 99.1 NOVADAQ TECHNOLOGIES INC. ANNUAL INFORMATION FORM For the year ended December 31, 2014 March 25, 2015 TABLE OF CONTENTS ITEM 1. CORPORATE STRUCTURE 4 1.1 Name, Address and Incorporation 4 1.2 Inter-Corporate Relationships 4 ITEM 2. GENERAL DEVELOPMENT OF THE BUSINESS 4 2.1 Overview 4 2.2 Three-Year History 5 ITEM 3. NARRATIVE DESCRIPTION OF THE BUSINESS 9 3.1 General 9 3.2 Bus |
|
| March 23, 2015 |
Novadaq Technologies FORM 6-K (Current Report of Foreign Issuer) Novadaq Technologies Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Sui |
|
| March 23, 2015 |
NOVADAQ To Participate in Upcoming Investor Conferences EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 For Immediate Release NOVADAQ To Participate in Upcoming Investor Conferences Toronto, ON – March 23, 2015 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will |
|
| March 9, 2015 |
Novadaq Technologies 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant?s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| March 9, 2015 |
NOVADAQ Announces Appointment of Patrice E. Merrin to Its Board of Directors EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Announces Appointment of Patrice E. Merrin to Its Board of Directors Toronto, ON ? March 9, 2015 ? Novadaq Technologies Inc. (?NOVADAQ? or the ?Company?) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that Patrice E. Mer |
|
| March 4, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of regi |
|
| March 4, 2015 |
NOVADAQ to Present at the 2015 Barclays Global Healthcare Conference EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Present at the 2015 Barclays Global Healthcare Conference Toronto, Ontario – March 4, 2015 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that its President and |
|
| February 26, 2015 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management’s Discussion and Analysis [“MD&A”] for NOVADAQ® Technologies Inc. [“NOVADAQ” or the “Company”] should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2014, which have been prepared in accordance with International Finan |
|
| February 26, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| February 26, 2015 |
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING EX-99.1 2 d880898dex991.htm EX-99.1 Exhibit 99.1 MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING The accompanying consolidated financial statements of Novadaq Technologies Inc. (the “Company”) and all the information in this annual report are the responsibility of management and have been approved by the Board of Directors. The financial statements have been prepared by management in accordanc |
|
| February 25, 2015 |
NOVADAQ Reports Fourth Quarter and Full Year 2014 Financial Results EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Reports Fourth Quarter and Full Year 2014 Financial Results Toronto, Ontario – February 25, 2015 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced its fourth quarter |
|
| February 25, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| February 11, 2015 |
NVDQ / Novadaq Technologies, Inc. / PRUDENTIAL FINANCIAL INC Passive Investment 13G HTML File DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 10, 2015 |
EX-99.1 2 d869511dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 – Conference Call to Follow Toronto, Ontario – February 10, 2015 - Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ;TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions fo |
|
| February 10, 2015 |
NOVADAQ To Participate in February Investor Conferences EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ To Participate in February Investor Conferences Toronto, ON – February 10, 2015 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in |
|
| February 10, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| February 10, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| January 12, 2015 |
EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Announces Fourth Quarter 2014 Preliminary Unaudited Revenues and Issues 2015 Revenue Guidance Toronto, ON – January 12, 2015 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announc |
|
| January 12, 2015 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2015 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| December 29, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| December 29, 2014 |
NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference EX-99.1 2 d843892dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Present at the 33rd Annual J.P. Morgan Healthcare Conference Toronto, Ontario – December 29, 2014 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, ann |
|
| December 22, 2014 |
NOVADAQ Announces Organizational Changes to Support Continued Growth EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Announces Organizational Changes to Support Continued Growth Toronto, Ontario – December 22, 2014 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced various changes to |
|
| December 22, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| December 10, 2014 |
NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health’s DermACELL Tissue Products EX-99.1 2 d835298dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health’s DermACELL Tissue Products TORONTO, ONTARIO – December 9, 2014 – Novadaq® Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures and LifeN |
|
| December 10, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| December 8, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| December 8, 2014 |
NOVADAQ Granted Additional SPY Technology Patent Protection in the U.S. EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Granted Additional SPY Technology Patent Protection in the U.S. Toronto, Ontario – December 8, 2014 – Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the recent grant |
|
| November 25, 2014 |
NOVADAQ to Participate in Piper Jaffray 26th Annual Healthcare Conference EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Participate in Piper Jaffray 26th Annual Healthcare Conference Toronto, Ontario – November 25, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that managem |
|
| November 25, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| November 7, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.3 Exhibit 99.3 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Arun Menawat, Chief Executive Officer at Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Novadaq Technologies Inc. (the “issuer”) for the interim period ended September 30, 2014. 2. No misrepresentati |
|
| November 7, 2014 |
March 2011 Shareholder Warrants EX-99.1 Exhibit 99.1 Novadaq Technologies Inc. INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) (expressed in U.S. dollars, except common shares outstanding) Notes As at September 30, 2014 As at December 31, 2013 ASSETS Current assets Cash and cash equivalents $ 157,750,437 $ 182,329,782 Accounts receivable 13,979,422 8,502,095 Prepaid expenses and other assets 1,624,020 |
|
| November 7, 2014 |
FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE EX-99.4 Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Stephen Purcell, Chief Financial Officer at Novadaq Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Novadaq Technologies Inc. (the “issuer”) for the interim period ended September 30, 2014. 2. No misrepresent |
|
| November 7, 2014 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 3 d817653dex992.htm EX-99.2 Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Management’s Discussion and Analysis [“MD&A”] for NOVADAQ® Technologies Inc. [“NOVADAQ” or the “Company”] should be read in conjunction with the unaudited interim condensed consolidated financial statements for the three and nine month periods ended September |
|
| November 7, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| November 6, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of r |
|
| November 6, 2014 |
NOVADAQ Reports Third Quarter 2014 Financial Results EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Reports Third Quarter 2014 Financial Results Toronto, Ontario – November 6, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third qu |
|
| October 30, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 30, 2014 |
NOVADAQ Announces Transfer of SPY® Elite Business from LifeCell Corporation EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Announces Transfer of SPY® Elite Business from LifeCell Corporation Toronto, Ontario – October 30, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it and |
|
| October 27, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 27, 2014 |
NOVADAQ to Participate in November Investor Healthcare Conferences EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Participate in November Investor Healthcare Conferences Toronto, Ontario – October 27, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will |
|
| October 22, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 22, 2014 |
EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan Mizuho to exclusively represent PINPOINT Fluorescence Imaging Toronto, Ontario – October 21, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical an |
|
| October 17, 2014 |
EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Release Third Quarter 2014 Financial Results on November 6, 2014 – Conference Call to Follow Toronto, Ontario – October 17, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or “the Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, |
|
| October 17, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 16, 2014 |
EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Appoints Kirloskar Technologies As Its Exclusive Distributor in India Canadian Minister of International Trade Hosts Signing Ceremony Toronto, Ontario – October 16, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use |
|
| October 16, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 2, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of re |
|
| October 2, 2014 |
EX-99.1 Exhibit 99.1 For Immediate Release Novadaq PINPOINT Studies Published in JACS and Annals of Surgery Pillar II Study and Esophagectomy Trial Results Now Available Toronto, Ontario – October 2, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and |
|
| September 30, 2014 |
NOVADAQ Announces Multi-Unit Agreement with SerenaGroup for LUNA EX-99.1 2 d795854dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ Announces Multi-Unit Agreement with SerenaGroup for LUNA Toronto, Ontario – September 30, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today an |
|
| September 30, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of |
|
| September 17, 2014 |
NOVADAQ to Host Analyst & Investor Day on November 17, 2014 EX-99.1 2 d791511dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Host Analyst & Investor Day on November 17, 2014 Toronto, Ontario – September 17, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an |
|
| September 17, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of |
|
| September 2, 2014 |
NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors Exhibit 99.1 For Immediate Release NOVADAQ Announces Appointment of Robert S. White to Its Board of Directors Toronto, Ontario – September 2, 2014 – Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Robert “Bob” S. White has b |
|
| September 2, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of |
|
| August 6, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of reg |
|
| August 6, 2014 |
NOVADAQ to Present at the Canaccord Genuity 34th Annual Growth Conference EX-99.1 2 d771516dex991.htm EX-99.1 Exhibit 99.1 For Immediate Release NOVADAQ to Present at the Canaccord Genuity 34th Annual Growth Conference TORONTO, August 6, 2014 (GLOBE NEWSWIRE) Novadaq® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced t |
|
| August 5, 2014 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS EX-99.2 Exhibit 99.2 MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This Managements Discussion and Analysis [MD&A] for Novadaq® Technologies Inc. [Novadaq or the Company] should be read in conjunction with the unaudited interim condensed consolidated financial statements for the three and six month periods ended June 30, 2014, which have been prepared |
|
| August 5, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address of registr |
|
| August 5, 2014 |
NVDQ / Novadaq Technologies, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 (Commission File No. 001-35446) NOVADAQ TECHNOLOGIES INC. (Translation of registrant’s name into English) 5090 Explorer Drive Suite 202, Mississauga Ontario, Canada L4W 4T9 (Address o |
